Literature DB >> 15745763

Risk of glaucoma in ocular hypertension with and without pseudoexfoliation.

Kirsti Grødum1, Anders Heijl, Bo Bengtsson.   

Abstract

PURPOSE: To compare glaucoma conversion rates in patients with ocular hypertension (OH) with and without pseudoexfoliation.
DESIGN: Cohort study, based on 32,918 screening participants. PARTICIPANTS AND CONTROLS: Ninety-eight patients with OH and pseudoexfoliation and 98 matched controls. MAIN OUTCOME MEASURE: Perimetric glaucoma conversion.
METHODS: A population-based glaucoma screening of elderly citizens of Malmö, Sweden, was conducted between 1992 and 1997 to recruit participants for the Early Manifest Glaucoma Trial. Screening participants with intraocular pressure (IOP) between 24 and 32 mmHg and pseudoexfoliation were compared to controls among other screening participants without pseudoexfoliation but matched for baseline IOP, age, and gender, and the 2 groups were invited to a reexamination. Computerized visual field tests were performed to identify persons with manifest glaucoma. Visual acuity, refraction, IOP, and central corneal thickness were also measured.
RESULTS: After a mean of 8.7 years (range: 6.3-11.4), 54 of 98 patients (55.1%) with pseudoexfoliation at the baseline examination and 27 of 98 patients (27.6%) without pseudoexfoliation had developed glaucoma. The risk ratio was 2.0 (P<0.0001).
CONCLUSION: The glaucoma conversion rate was twice as high in patients with OH and pseudoexfoliation as in control patients matched for IOP, age, and gender. Thus, pseudoexfoliation was a strong independent risk factor for glaucoma in patients with OH.

Entities:  

Mesh:

Year:  2005        PMID: 15745763     DOI: 10.1016/j.ophtha.2004.09.024

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  27 in total

1.  Scanning laser ophthalmoscopic parameters of eyes with exfoliation syndrome.

Authors:  Ali Bulent Cankaya; Emrullah Beyazyildiz
Journal:  Jpn J Ophthalmol       Date:  2010-08-11       Impact factor: 2.447

2.  [Medicinal glaucoma therapy. What can we learn from large randomized clinical trials?].

Authors:  A G M Jünemann; C Huchzermeyer; R Rejdak
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

Review 3.  The medical and surgical management of pseudoexfoliation glaucoma.

Authors:  Manishi A Desai; Richard K Lee
Journal:  Int Ophthalmol Clin       Date:  2008

4.  Genetics, Diagnosis, and Monitoring of Pseudoexfoliation Glaucoma.

Authors:  Niraj Nathan; Rachel W Kuchtey
Journal:  Curr Ophthalmol Rep       Date:  2016-10-11

Review 5.  [New pathogenetic insights into pseudoexfoliation syndrome/glaucoma. Therapeutically relevant?].

Authors:  U Schlötzer-Schrehardt
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

6.  Optical coherence tomography angiography of the peripapillary region and macula in normal, primary open angle glaucoma, pseudoexfoliation glaucoma and ocular hypertension eyes.

Authors:  Helin Ceren Köse; Oya Tekeli
Journal:  Int J Ophthalmol       Date:  2020-05-18       Impact factor: 1.779

Review 7.  [Diagnosis and therapy of pseudoexfoliation glaucoma].

Authors:  A G M Jünemann
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

8.  Trabeculotomy combined with phacoemulsification, intraocular lens implantation and sinusotomy for exfoliation glaucoma.

Authors:  Takeo Fukuchi; Jun Ueda; Tomoko Nakatsue; Kieko Suda; Hiroaki Hara; Haruki Abe
Journal:  Jpn J Ophthalmol       Date:  2011-05-11       Impact factor: 2.447

Review 9.  Genomic and proteomic pathophysiology of pseudoexfoliation glaucoma.

Authors:  Luis E Vazquez; Richard K Lee
Journal:  Int Ophthalmol Clin       Date:  2014

10.  Retrobulbar hemodynamic parameters in pseudoexfoliation syndrome and pseudoexfoliative glaucoma.

Authors:  Antonio Martinez; Manuel Sanchez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-05-20       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.